MDS-460 Impact of Venetoclax on High-Risk Myelodysplastic Syndromes: A Retrospective Multicenter Analysis of Azacitidine-Venetoclax vs Azacitidine Monotherapy in Mexico

Autor: Chacon-Rangel, Lyam Carlo, Rodriguez-Rodriguez, Sergio, Ontiveros-Austria, Juan Luis, Demichelis-Gomez, Roberta, Gomez-De Leon, Andres, Rodriguez-Zuñiga, Anna C., Inclan-Alarcon, Sergio Ignacio, Corral-Herrera, Veronica Steffania, Zapata-Canto, Nidia Paulina, Apodaca-Chavez, Elia Ixel
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S396-S397
Databáze: ScienceDirect
Externí odkaz: